Chromos Molecular Systems Inc. (CHR-T Unlisted) Stock Predictions - Stockchase
WATCH LIST
3
Chromos Molecular Systems Inc. (CHR-T Unlisted)

ON STOCKCHASE SINCE Nov 2004

Make artificial chromosones.

biotechnology/pharmaceutical

Chromos Molecular Systems...

CHR-T Unlisted

12 watching          
Join the Discussion

Chromos Molecular Systems Inc. (CHR-T Unlisted) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about CHR-T Unlisted



  • All
  • Filtered
Signal Opinion Expert
BUY

Likes the story. They’ve switched their contract and he feels the company came out very well in the negotiations. They moved from a spread over costs which Air Canada (AC-T) used to pay, to a fixed price contract, which is very good for this company. Over the duration of the 10 years that the contract was reset for, the dividend is sustainable.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Likes the story. They’ve switched their contract and he feels the company came out very well in the negotiations. They moved from a spread over costs which Air Canada (AC-T) used to pay, to a fixed price contract, which is very good for this company. Over the duration of the 10 years that the contract was reset for, the dividend is sustainable.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew Pink

Portfolio , LDIC...

Price Price
$0.040
Owned Owned
Yes

BUY

(Market Call Minute) They love it.  The company is not responsible for any of the variable costs.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(Market Call Minute) They love it.  The company is not responsible for any of the variable costs.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bruce Murray

CEO & Chie, The Murray Wealth Gr...

Price Price
$0.040
Owned Owned
Unknown

HOLD
Good technology which should win Nobel prizes 5/10 years. Running out of cash. The big question is; will they survive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Good technology which should win Nobel prizes 5/10 years. Running out of cash. The big question is; will they survive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Duncan Stewart

Director o, DSAM Consulting...

Price Price
$0.570
Owned Owned
Yes

Showing 1 to 3 of 3 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days